2017 Wmif Disruptive Dozen 12

Moderators: Calum MacRae, MD, PhD, Chief of Cardiovascular Medicine, Brigham and Women's Hospital; Associate Professor of ... Nanotechnology and Cancer Treatment Introduction by: Monica Bertagnolli, MD, Chief, Division of Surgical Oncology, BWH, ... Moderator: Katherine Andriole, PhD, Director of Research Strategy and Operations, MGH & BWH CCDS; Associate Professor, ... A widely used administrative tool in U.S. health care, which is meant to control costs while ensuring quality, is getting a major ... 2022 WMIF Disruptive Dozen 12 Technologies that will Reinvent GCT in the Next Five Years Nearly one hundred senior Mass General Brigham Harvard faculty contributed to the creation of this group of

4: Rapid Intervention for Psychiatric Disorders Leading CNS faculty from the Brigham and Women's Hospital, Massachusetts ... Rudolph Tanzi, PhD, Director, Genetics and Aging Research Unit, MassGeneral Institute for Neurodegenerative Disease ... Redefining Value in Cancer Care Introduction by: Daniel Haber, MD, PhD, Director, MGH Cancer Center, Kurt J. Isselbacher/Peter ... 7: New Aspects of Gene Therapy Leading CNS faculty from the Brigham and Women's Hospital, Massachusetts General Hospital, ... Reawakening the X-Chromosome: A Therapeutic Strategy for Devastating Neurodevelopmental Diseases The biology of the X ... Patient-Specific Research to Enable Efficient Drug Development Introduction by: Daniel Haber, MD, PhD, Director, MGH Cancer ...

11: Neuroimaging for Neurodegenerative and Psychiatric Disorders Leading CNS faculty from the Brigham and Women's Hospital ... The Microbiome and Cancer Introduction by: Monica Bertagnolli, MD, Chief, Division of Surgical Oncology, BWH, Professor of ... 10: Immune Checkpoint Inhibitors for Brain Cancer Leading CNS faculty from the Brigham and Women's Hospital, Massachusetts ...